These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Controlling cancer by restricting arginine availability--arginine-catabolizing enzymes as anticancer agents. Wheatley DN Anticancer Drugs; 2004 Oct; 15(9):825-33. PubMed ID: 15457122 [TBL] [Abstract][Full Text] [Related]
5. Molecular basis and current strategies of therapeutic arginine depletion for cancer. Fultang L; Vardon A; De Santo C; Mussai F Int J Cancer; 2016 Aug; 139(3):501-9. PubMed ID: 26913960 [TBL] [Abstract][Full Text] [Related]
6. Arginine dependence of tumor cells: targeting a chink in cancer's armor. Patil MD; Bhaumik J; Babykutty S; Banerjee UC; Fukumura D Oncogene; 2016 Sep; 35(38):4957-72. PubMed ID: 27109103 [TBL] [Abstract][Full Text] [Related]
7. Amino Acids Sequence-based Analysis of Arginine Deiminase from Different Prokaryotic Organisms: An In Silico Approach. Abdollahi S; Morowvat MH; Savardashtaki A; Irajie C; Najafipour S; Zarei M; Ghasemi Y Recent Pat Biotechnol; 2020; 14(3):235-246. PubMed ID: 32208128 [TBL] [Abstract][Full Text] [Related]
8. Sensitivity of Colorectal Cancer to Arginine Deprivation Therapy is Shaped by Differential Expression of Urea Cycle Enzymes. Alexandrou C; Al-Aqbi SS; Higgins JA; Boyle W; Karmokar A; Andreadi C; Luo JL; Moore DA; Viskaduraki M; Blades M; Murray GI; Howells LM; Thomas A; Brown K; Cheng PN; Rufini A Sci Rep; 2018 Aug; 8(1):12096. PubMed ID: 30108309 [TBL] [Abstract][Full Text] [Related]
9. Arginine deprivation as a strategy for cancer therapy: An insight into drug design and drug combination. Zhang Y; Chung SF; Tam SY; Leung YC; Guan X Cancer Lett; 2021 Apr; 502():58-70. PubMed ID: 33429005 [TBL] [Abstract][Full Text] [Related]
10. Biochemical characterization of the arginine degrading enzymes arginase and arginine deiminase and their effect on nitric oxide production. Dillon BJ; Holtsberg FW; Ensor CM; Bomalaski JS; Clark MA Med Sci Monit; 2002 Jul; 8(7):BR248-53. PubMed ID: 12118186 [TBL] [Abstract][Full Text] [Related]
11. Arginine Metabolism in Bacterial Pathogenesis and Cancer Therapy. Xiong L; Teng JL; Botelho MG; Lo RC; Lau SK; Woo PC Int J Mol Sci; 2016 Mar; 17(3):363. PubMed ID: 26978353 [TBL] [Abstract][Full Text] [Related]
12. Arginine metabolism and deprivation in cancer therapy. Zou S; Wang X; Liu P; Ke C; Xu S Biomed Pharmacother; 2019 Oct; 118():109210. PubMed ID: 31330440 [TBL] [Abstract][Full Text] [Related]
13. Arginine Deiminase: Current Understanding and Applications. Zarei M; Rahbar MR; Morowvat MH; Nezafat N; Negahdaripour M; Berenjian A; Ghasemi Y Recent Pat Biotechnol; 2019; 13(2):124-136. PubMed ID: 30569861 [TBL] [Abstract][Full Text] [Related]
14. Unlocking the Potential of Arginine Deprivation Therapy: Recent Breakthroughs and Promising Future for Cancer Treatment. Chu YD; Lai MW; Yeh CT Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445845 [TBL] [Abstract][Full Text] [Related]
15. Cancer cell sensitivity to arginine deprivation in vitro is not determined by endogenous levels of arginine metabolic enzymes. Bobak YP; Vynnytska BO; Kurlishchuk YV; Sibirny AA; Stasyk OV Cell Biol Int; 2010 Nov; 34(11):1085-9. PubMed ID: 20653567 [TBL] [Abstract][Full Text] [Related]
16. Biochemical characterization of the arginine degrading enzymes arginase and arginine deiminase and their effect on nitric oxide production. Sezgin N; Torun T; Yalcin F Med Sci Monit; 2002 Oct; 8(10):LE44. PubMed ID: 12434793 [No Abstract] [Full Text] [Related]
18. Amino Acid Degrading Enzymes and their Application in Cancer Therapy. Pokrovsky VS; Chepikova OE; Davydov DZ; Zamyatnin AA; Lukashev AN; Lukasheva EV Curr Med Chem; 2019; 26(3):446-464. PubMed ID: 28990519 [TBL] [Abstract][Full Text] [Related]
19. Anti-tumor activity of arginine deiminase via arginine deprivation in retinoblastoma. Kim JH; Kim JH; Yu YS; Kim DH; Min BH; Kim KW Oncol Rep; 2007 Dec; 18(6):1373-7. PubMed ID: 17982619 [TBL] [Abstract][Full Text] [Related]
20. The role of arginine and the modified arginine deiminase enzyme ADI-PEG 20 in cancer therapy with special emphasis on Phase I/II clinical trials. Synakiewicz A; Stachowicz-Stencel T; Adamkiewicz-Drozynska E Expert Opin Investig Drugs; 2014 Nov; 23(11):1517-29. PubMed ID: 24965808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]